Oxgen Pharmaceuticals recently released a report concluding that Jeloco Pharmaceuticals' products are unsafe and are known to cause birth defects. This report cannot be trusted, however, since Oxgen is Jeloco's rival and they are currently in competition for a large grant for drug research. Oxgen's report is biased, and so it is clear that there is nothing wrong with Jeloco's products and they do not cause birth defects.
The reasoning in the preceding passage is most vulnerable to criticism on the grounds that it
A)Treats evidence showing bias as evidence showing falsehoods.
B)Draws an conclusion from an unrepresentative sample.
C)Fails to take into account the untrustworthy nature of studies regarding birth defects.
D)Presumes, without providing justification, that Oxgen had reason to embellish its claims against Jeloco.
E)Presumes, without providing justification, that two competitors would have reason to criticize the other.

Question

Quizplus · Accepted Answer

The reasoning in the passage is most vulnerable to criticism on the grounds that it treats evidence showing bias as evidence showing falsehoods. The passage does give enough reason to suggest bias on the part of Oxgen and therefore treat the report as suspect, but does not give enough evidence to discredit the report and draw the opposite conclusion.

Oxgen Pharmaceuticals Recently Released a Report Concluding That Jeloco Pharmaceuticals